ArticlesBoston
Consano Bio Raises $15M
Consano Bio raises $15M.
By Traded Media1 min read
Consano Bio raises $15M Series A+ led by Conviction.
Participants in this funding round include various investors eager to support advancements in healthcare.
Consano Bio develops therapeutics designed to address serious, painful orthopedic conditions. The company is led by CEO Andrew Hall.
| Company | Consano Bio |
|---|---|
| Amount | $15M |
| Founders | Andrew Hall, Conviction Andrew Hall |
| Sectors | Biotechnology |
ABOUT THIS STORY
- Desk
- Articles
- Filed
- Oct 5, 2026
- By
- Traded Media